143 related articles for article (PubMed ID: 15191000)
1. Efficacy of risperidone for treating patients with behavioral and psychological symptoms of dementia.
Wancata J
Int Psychogeriatr; 2004 Mar; 16(1):107-15. PubMed ID: 15191000
[TBL] [Abstract][Full Text] [Related]
2. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.
Zaudig M
Drug Saf; 2000 Sep; 23(3):183-95. PubMed ID: 11005702
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of risperidone in the treatment of behavioral and psychological symptoms and sleep disturbances associated with dementia.
Durán JC; Greenspan A; Diago JI; Gallego R; Martinez G
Int Psychogeriatr; 2005 Dec; 17(4):591-604. PubMed ID: 16202185
[TBL] [Abstract][Full Text] [Related]
4. Effects of risperidone on behavioral and psychological symptoms associated with dementia in clinical practice.
Kurz A; Schwalen S S; Schmitt A
Int Psychogeriatr; 2005 Dec; 17(4):605-16. PubMed ID: 16185378
[TBL] [Abstract][Full Text] [Related]
5. Effect of risperidone on behavioral and psychological symptoms and cognitive function in dementia.
Rainer MK; Masching AJ; Ertl MG; Kraxberger E; Haushofer M
J Clin Psychiatry; 2001 Nov; 62(11):894-900. PubMed ID: 11775050
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
[TBL] [Abstract][Full Text] [Related]
8. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.
Katz IR; Jeste DV; Mintzer JE; Clyde C; Napolitano J; Brecher M
J Clin Psychiatry; 1999 Feb; 60(2):107-15. PubMed ID: 10084637
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances.
Suh GH; Son HG; Ju YS; Jcho KH; Yeon BK; Shin YM; Kee BS; Choi SK
Am J Geriatr Psychiatry; 2004; 12(5):509-16. PubMed ID: 15353389
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
[TBL] [Abstract][Full Text] [Related]
11. Open-label, observational study of the effects of risperidone on the behavioral and psychological symptoms of dementia and caregiver stress in the community setting.
Arriola E; Ignacio Diago J; Antonio Burón J; Gallego R;
Am J Geriatr Pharmacother; 2005 Mar; 3(1):8-16. PubMed ID: 16089242
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
Angelini A; Bendini C; Neviani F; Neri M
Arch Gerontol Geriatr; 2007; 44 Suppl 1():35-43. PubMed ID: 17317431
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.
Rabinowitz J; Katz IR; De Deyn PP; Brodaty H; Greenspan A; Davidson M
J Clin Psychiatry; 2004 Oct; 65(10):1329-34. PubMed ID: 15491235
[TBL] [Abstract][Full Text] [Related]
14. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
15. A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). Favour.
Shah A; Suh GH
Int Psychogeriatr; 2005 Mar; 17(1):12-22; discussion 22-9. PubMed ID: 15945589
[No Abstract] [Full Text] [Related]
16. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).
Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G
Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
Kurz A; Delius-Stute H; Rettig K; Schwalen S
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of risperidone oral solution in agitation associated with dementia in the elderly.
Laks J; Engelhardt E; Marinho V; Rozenthal M; Souza FC; Bacaltchuk J; Stoppe A; Ferreira RC; Bottino C; Scalco M
Arq Neuropsiquiatr; 2001 Dec; 59(4):859-64. PubMed ID: 11733828
[TBL] [Abstract][Full Text] [Related]
19. Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia.
Bhana N; Spencer CM
Drugs Aging; 2000 Jun; 16(6):451-71. PubMed ID: 10939309
[TBL] [Abstract][Full Text] [Related]
20. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
De Deyn PP; Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():19-22. PubMed ID: 11584983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
